Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-15

FDA Approved: TERIFLUNOMIDE — Original Application (Natco Pharma USA LLC)

View source ↗

Summary

FDA approved Natco Pharma USA LLC's original application for generic teriflunomide, a disease-modifying therapy for relapsing forms of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriflunomide (teriflunomide)

Snippet

ORIG AP for TERIFLUNOMIDE (TERIFLUNOMIDE)